A detailed history of Perceptive Advisors LLC transactions in En V Veno Medical Corp stock. As of the latest transaction made, Perceptive Advisors LLC holds 694,315 shares of NVNO stock, worth $2.37 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
694,315
Previous 623,315 11.39%
Holding current value
$2.37 Million
Previous $3.27 Million 28.73%
% of portfolio
0.06%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.24 - $6.19 $230,040 - $439,490
71,000 Added 11.39%
694,315 $2.33 Million
Q4 2023

Feb 14, 2024

SELL
$3.46 - $5.73 $547,718 - $907,059
-158,300 Reduced 20.25%
623,315 $3.2 Million
Q4 2021

Feb 14, 2022

BUY
$6.23 - $10.24 $4.87 Million - $8 Million
781,615 New
781,615 $5.15 Million

Others Institutions Holding NVNO

About enVVeno Medical Corp


  • Ticker NVNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 9,469,850
  • Market Cap $32.3M
  • Description
  • enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...
More about NVNO
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.